RecruitingNot ApplicableNCT07597005

Red Propolis Supplementation as a Strategy in Chronic Kidney Disease

Red Propolis as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease

Sponsor

Universidade Federal Fluminense

Enrollment

40 participants

Start Date

Sep 30, 2025

Study Type

INTERVENTIONAL

Conditions

Chronic Kidney Disease Kidney Disease Inflammation Oxidative Stress

Summary

The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo Control and Red Propolis for people with chronic kidney disease, inflammation, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTRed Propolis

Participants will receive 200mg of red propolis capsules per day for two months.

OTHERPlacebo Control

Participants will receive 200mg of placebo capsules per day for two months.

Locations(1)

Denise Mafra

Rio de Janeiro, Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07597005

Related Trials

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

NCT0354975476 locations

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

NCT038897438 locations